Clinical Trial

Switching to E-Cigarettes After Type 2 Diabetes Diagnosis and Health Outcomes

Name: Switching to E-Cigarettes After Type 2 Diabetes Diagnosis and Health Outcomes — clinical trial record (NCT07414355)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: E-cig-DM

Completed

View on ClinicalTrials.gov →

Summary

Individuals with T2DM who smoke have higher risks of cardiovascular disease and other complications. Many people consider e-cigarette as a "harm-reduction" alternatives to combustible cigarettes, but it is not clear whether switching to e-cigarettes improves health outcomes in patients with diabetes.

Trial Details

NCT Number	NCT07414355
Lead Sponsor	Samsung Medical Center
Conditions	Diabete Type 2, E Cigarette Use, Clinical Outcomes
Enrollment	133,320 participants
Start Date	2018-01-01
Primary Completion	2023-12-31 (estimated)
Study Completion	2023-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-17